Evaluation of BRUDYGLAUCO (DHA + Citicoline) in Patients With Glaucoma — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Evaluation of BRUDYGLAUCO (DHA + Citicoline) in Patients With Glaucoma — Stella

Recruiting

Back to Glaucoma trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(2 sites)

Spain

Institut Català de Retina, Barcelona, Barcelona

Hospital del Mar | Centre Esperança, Barcelona, Barcelona

Key details

Sponsor

Institut Catala de Retina

Collaborators

Hospital de la Esperanza

Enrollment target

~108 participants

Started

April 2025

Primary completion

April 2027

Age range

50 Years – 75 Years

Last updated January 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov